Articles

Dialogue | William Hu and Insilico Medicine's Ren Feng on How AI Is Driving Next-Generation Drug Discovery

Dialogue | William Hu and Insilico Medicine's Ren Feng on How AI Is Driving Next-Generation Drug Discovery

For AI drug discovery companies, it's not enough to possess proprietary core technologies — they must also embed themselves deeply into the practical scenarios of pharmaceutical R&D, driving those technologies toward real-world implementation and commercial translation.